Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot Infections

NCT00044746 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

314

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus
Diabetic Foot

Interventions

DRUG: Piperacillin/Tazobactam

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer